CAS 919351-41-0
:AZD1283
Description:
AZD1283, with the CAS number 919351-41-0, is a chemical compound that has been investigated primarily for its potential therapeutic applications, particularly in the context of diabetes and metabolic disorders. It is classified as a small molecule and functions as a selective inhibitor of certain enzymes involved in glucose metabolism. AZD1283 has been shown to modulate insulin sensitivity and improve glycemic control in preclinical studies. The compound exhibits a specific mechanism of action that targets pathways related to glucose homeostasis, making it a candidate for further research in the treatment of type 2 diabetes. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its efficacy and safety profile. As with many investigational drugs, ongoing studies are essential to fully elucidate its therapeutic potential and any associated side effects. Overall, AZD1283 represents a promising avenue in the development of new treatments for metabolic diseases.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
AZD1283
CAS:<p>AZD1283 is an effective P2Y12 receptor antagonist (EC50: 3.0 ug/kg/min, binding IC50: 11 nM).</p>Formula:C23H26N4O5SPurity:98.37% - 99.63%Color and Shape:SolidMolecular weight:470.54AZD 1283
CAS:<p>AZD 1283 is a compound that was designed to target the P2Y receptor. It is a potent antagonist of this receptor which has been shown to be involved in platelet aggregation, collagen metabolism, and cancer. AZD 1283 also blocks the thrombin receptor and ATP production, which may lead to improved cardiovascular outcomes. AZD 1283 has been shown to have potential therapeutic applications for autoimmune diseases such as rheumatoid arthritis.</p>Formula:C23H26N4O5SPurity:Min. 95%Molecular weight:470.54 g/mol
